484 related articles for article (PubMed ID: 26893156)
1. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
[TBL] [Abstract][Full Text] [Related]
2. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
3. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
4. G-CSF treatment promotes apoptosis of autoreactive T cells to restrict the inflammatory cascade and accelerate recovery in experimental allergic encephalomyelitis.
Peng W
Exp Neurol; 2017 Mar; 289():73-84. PubMed ID: 27771353
[TBL] [Abstract][Full Text] [Related]
5. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
6. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
7. Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
Mimura LA; Chiuso-Minicucci F; Fraga-Silva TF; Zorzella-Pezavento SF; França TG; Ishikawa LL; Penitenti M; Ikoma MR; Sartori A
Neuroscience; 2016 Mar; 317():130-40. PubMed ID: 26762804
[TBL] [Abstract][Full Text] [Related]
8. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
9. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
10. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Bozoyan L; Dumas A; Patenaude A; Vallières L
J Neuroinflammation; 2015 Sep; 12():173. PubMed ID: 26377915
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
[TBL] [Abstract][Full Text] [Related]
13. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Xu J; Wagoner G; Douglas JC; Drew PD
J Neuroimmunol; 2013 Jan; 254(1-2):46-54. PubMed ID: 23010281
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Wang D; Li SP; Fu JS; Bai L; Guo L
Int J Dev Neurosci; 2016 Apr; 49():60-6. PubMed ID: 26827767
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
16. Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
Ueno R; Miyamoto K; Tanaka N; Moriguchi K; Kadomatsu K; Kusunoki S
J Neurosci Res; 2015 Dec; 93(12):1874-80. PubMed ID: 26340909
[TBL] [Abstract][Full Text] [Related]
17. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
[TBL] [Abstract][Full Text] [Related]
19. 2-BFI ameliorates EAE-induced mouse spinal cord damage: effective therapeutic time window and possible mechanisms.
Li F; Zhang ZX; Liu YF; Xu HQ; Hou ST; Zheng RY
Brain Res; 2012 Nov; 1483():13-9. PubMed ID: 22985669
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
